Inari Medical Inc
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-… Read more
Inari Medical Inc (NARI) - Total Liabilities
Latest total liabilities as of September 2024: $262.48 Million USD
Based on the latest financial reports, Inari Medical Inc (NARI) has total liabilities worth $262.48 Million USD as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Inari Medical Inc - Total Liabilities Trend (2018–2023)
This chart illustrates how Inari Medical Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Inari Medical Inc Competitors by Total Liabilities
The table below lists competitors of Inari Medical Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Tubize-Fin
BR:TUB
|
Belgium | €367.02K |
|
Shenzhen Woer Heat-Shrinkable Material Co Ltd
SHE:002130
|
China | CN¥5.23 Billion |
|
Edenred SA
PA:EDEN
|
France | €14.37 Billion |
|
Urban Outfitters Inc
NASDAQ:URBN
|
USA | $2.20 Billion |
|
Ono Pharmaceutical Co. Ltd
PINK:OPHLF
|
USA | $239.25 Billion |
|
Skyline Corporation
NYSE:SKY
|
USA | $522.09 Million |
|
Mueller Water Products
NYSE:MWA
|
USA | $828.60 Million |
|
Alkermes Plc
NASDAQ:ALKS
|
USA | $710.96 Million |
Liability Composition Analysis (2018–2023)
This chart breaks down Inari Medical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.77 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.60 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Inari Medical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Inari Medical Inc (2018–2023)
The table below shows the annual total liabilities of Inari Medical Inc from 2018 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $209.32 Million | +140.19% |
| 2022-12-31 | $87.15 Million | +20.48% |
| 2021-12-31 | $72.33 Million | +422.71% |
| 2020-12-31 | $13.84 Million | -83.47% |
| 2019-12-31 | $83.69 Million | +26.14% |
| 2018-12-31 | $66.35 Million | -- |